Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer

Prostate

Volumn 35, Issue 4, 1998, Pages 285-296

  Costello, L C ^a   Franklin, R B ^a  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

Author keywords

Aconitase; Citrate; Energy production; Krebs cycle; Prolactin; Prostate cancer; Prostate cells; Testosterone; Zinc

Indexed keywords

ACONITATE HYDRATASE; CITRIC ACID; MITOCHONDRIAL ENZYME; PROLACTIN; TESTOSTERONE; ZINC;

CANCER DIAGNOSIS; CARCINOGENESIS; CELLULAR DISTRIBUTION; CITRIC ACID CYCLE; DIETARY INTAKE; DRUG DEVELOPMENT; ENERGY METABOLISM; ENZYME INHIBITION; HORMONAL REGULATION; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; REVIEW; ZINC METABOLISM;

ACONITATE HYDRATASE; ADENOCARCINOMA; ANIMALS; CITRATES; HOMEOSTASIS; HUMANS; MALE; MODELS, BIOLOGICAL; PRECANCEROUS CONDITIONS; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RATS; ZINC;

EID: 0032102939     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19980601)35:4<285::AID-PROS8>3.0.CO;2-F     Document Type: Review

References (47)

1. Mann T: Male accessories organs of reproduction and their secretion product. In Mann T (ed): "The Biochemistry of Semen and of the Male Reproductive Tract," New York: Wiley, 1964: 41-48.
2. Byar D: Zinc in male sex accessory organs. In Brandes D (ed): "Male Accessory Sex Organs," New York: Academic Press, 1974:161-171.
3. Rosoff B: Studies of zinc in normal and neoplastic prostatic tissues. In Murphy GP, Sandberg AA, Karr JP (eds): "The Prostatic Cell: Structure and Function," New York: Liss, 1981:447-4157.
4. Vallee BL: Biochemistry, physiology and pathology of zinc. Physiol Rev 1992;39:443-490.
5. Valley BL, Falchuk KH: The biochemical basis of zinc physiology. Physiol Rev 1993;73:79-118.
6. Gyorkey F, Min K-W, Huff JA, Gyorkey P: Zinc and magnesium in human prostate gland: Normal, hyperplastic, and neoplastic. Cancer Res 1967;27:1349-1353.
7. Lahtonen R: Zinc and cadmium concentrations in whole tissue and in separated epithelium and stroma from human benign prostatic hypertrophic glands. Prostate 1985;6:177-183.
8. Gonic P, Oberleas D, Knechtges T, Prasad AS: Atomic absorption determination of zinc in the prostate. Invest Urol 1969;6: 345-347.
9. Thomas JA, Donovan MP, Waalkes MP, Curto KA: Interactions between protein and heavy metals in the rodent prostatic cell. In Murphy GP, Sandberg AA, Karr JP (eds): "The Prostatic Cell: Structure and Function," New York: Liss, 1981:459-474.
10. Lu Y, Costello LC, Franklin RB: Prolactin and testosterone regulation of mitochondrial zinc in prostate epithelial cells. Prostate 1997;30:26-32.
11. Kar AB, Chowdhury AR: The distribution of zinc in the subcellular fractions of the rhesus monkey and rat prostate. J Urol 1966;96:370-371.
12. Dhar NK, Goel TC, Dube PC, Chowdhury AR, Kar AB: Distribution and concentration of zinc in the subcellular fractions of benign hyperplastic and malignant neoplastic human prostate. Exp Mol Pathol 1973;19:139-142.
13. Larue JP, Morfin RF: Identification of a low molecular weight ligand for zinc in the human hyperplastic prostate. Endocr Res 1984;10:171-181.
14. Larue JP, Morfin RF: Effects of steroid androgens on the uptake and distribution of zinc in slices from human prostates. Endocr Res 1984;10:183-192.
15. Kavanagh JP: Zinc binding properties of human prostatic tissue, prostatic secretion and seminal fluid. J Reprod Fertil 1983;69: 359-363.
16. Franklin RB, Lao L, Costello LC: Evidence for two aspartate transport systems in prostate epithelial cells. Prostate 1990;16: 137-146.
17. Gunn SA, Gould TC: Difference between dorsal and lateral components of dorsolateral prostate of rat in Zn65 uptake. Proc Soc Exp Med 1957;92:17-20.
18. Müntzing J, Kirdani R, Murphy GP, Sandberg AA: Hormonal control of zinc uptake and binding in the rat dorsolateral prostate. Invest Urol 1977;14:492-495.
19. Habib FK, Mason MK, Smith PH, Stitch SR: Cancer of the prostate: Early diagnosis by zinc and hormone analysis. Br J Cancer 1979;39:700-704.
20. Ogunlewe JO, Osegbe DN: Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate. Cancer 1989;63:1388-1392.
21. Feustal A, Wennrich R, Steiniger D, Klauss P: Zinc and cadmium concentration in prostatic carcinoma of different histological grading in comparison to normal prostate tissue and adenofibromyomatosis (BPH). Urol Res 1982;10:301-303.
22. Lao L, Franklin RB, Costello LC: High-affinity L-aspartate transporter in prostate epithelial cells that is regulated by testosterone. Prostate 1993;22:53-63.
23. Costello LC, Lao L, Franklin RB: Citrate modulation of high-affinity aspartate transport in prostate epithelial cells. Cell Mol Biol 1994;39:515-524.
24. Costello LC, Franklin RB: Concepts of citrate production and secretion by prostate: 1. Metabolic relationships. Prostate 1991; 18:25-46.
25. Costello LC, Franklin RB: Concepts of citrate production and secretion by prostate: 2. Hormonal relationships in normal and neoplastic prostate. Prostate 1991;19:181-205.
26. Costello LC, Franklin RB: Effect of prolactin on the prostate. Prostate 1991;24:162-166.
27. Costello LC, Franklin RB: Citrate metabolism of normal and malignant prostate epithelial cells. Urology 1997;50:3-12.
28. Franklin RB, Costello LC: Intermediary energy metabolism of normal and malignant prostate epithelial cells. In Naz RK (ed): "Prostate: Basic and Clinical Aspects," New York: CRC Press, 115-150.
29. Costello LC, Franklin RB: Aconitase activity, citrate oxidation, and zinc inhibition in rat ventral prostate. Enzyme 1981;26:281-287.
30. Costello LC, Liu Y, Franklin RB: Testosterone stimulates the biosynthesis of m-aconitase and citrate oxidation in prostate epithelial cells. Mol Cell Endocrinol 1995;112:45-51.
31. Liu Y, Costello LC, Franklin RB: Prolactin specifically regulates citrate oxidation and m-aconitase of rat prostate epithelial cells. Metabolism 1996;45:442-449.
32. Costello LC, Liu Y, Franklin RB, Kennedy MC: Zinc inhibition of mitochondrial aconitase and its importance in citrate metabolism of prostate epithelial cells. J Biol Chem 1997;272:28875-28881.
33. Costello LC, Liu Y, Franklin RB: Testosterone and prolactin stimulation of mitochondrial aconitase in pig prostate epithelial cells. Urology 1996;48:654-659.
34. Franklin RB, Khang MW, Akuffo V, Costello LC: The effect of testosterone on citrate synthesis and citrate oxidation and a proposed mechanism for regulation of net citrate production in prostate. Horm Metab Res 1986;18:177-181.
35. Cooper JE, Farid I: The role of citric acid in the physiology of the prostate. A chromatographic study of citric acid cycle intermediates in benign and malignant prostatic tissue. J Surg Res 1963; 3:112-121.
36. Cooper JE, Farid I: The role of citric acid in the physiology of the prostate. Lactic/citrate ratios in benign and malignant prostatic homogenates as an index of prostatic malignancy. J Urol 1964; 92:533-536.
37. Costello LC, Franklin RB: The bioenergetic theory of prostate malignancy. Prostate 1994;25:162-166.
38. Kurhanewicz J, Dahiya R, MacDonald JM, Chang L-H, James TL, Narayan P: Citrate alterations in primary and metastatic human prostatic adenocarcinomas. 1H magnetic resonance spectroscopy and biochemical study. Magn Reson Med 1993;29:149-157.
39. Kurhanewicz J, Vigneron, DB, Nelson SJ, Hricak H, MacDonald JM, Konety B Narayan P: Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: Detection via localized proton spectroscopy. Urology 1995;45:459-467.
40. Kurhanewicz J, Vigneron DB, Hricak, H, Narayan P, Carroll P, Nelson SJ: Three dimensional hydrogen-1 MR spectroscopic imaging of the in situ human prostate with high spatial resolution. Radiology 1996;198:795-805.
41. Kurhanewicz J, Vigneron DB, Hricak H, Parivar F, Nelson SJ, Shinohara K, Carroll PR: Prostate cancer: Metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. Radiology 1996;200:489-496.
42. Schiebler ML, Miyamoto KK, White M, Maygarden SL, Mohler JL: In vitro high resolution 1H-spectroscopy of the human prostate: Benign prostatic hyperplasia, normal peripheral zone and adenocarcinoma. Magn Reson Med 1993;29:285-291.
43. Heerschap A, Jager GJ, Van Der Graaf M, Barentsz JO, De La Rosette J, Oosterhoff GO, Ruijter E, Ruijs S: In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue. Anticancer Res 1997;17:1455-1460.
44. Heerschap A, Jager GJ, Van Der Graaf M, Barentsz JO, Ruijs S: Proton MR spectroscopy of the normal human prostate with an endorectal coil and a double spin-echo pulse sequence. Magn Reson Med 1997;37:204-213.
45. Rosoff B, Diamond EJ: Effect of perphenazine on growth and zinc-65 uptake of the rat prostatic adenocarcinoma, R 3327. Prostate 1982;3:615-622.
46. Franklin RB, Zou J, Costello LC: Effect of zinc on proliferation of human prostate cancer cells. Urol Res 1995;23:266.
47. Franklin RB, Zou J, Gorski E, Yang YH, Costello LC: Prolactin regulation of mitochondriaL aspartate aminotransferase and protein kinase C in human prostate cancer cells. MoL Cell Endocrinol 1997;127:19-25.